Literature DB >> 14520515

The production of anti-inflammatory cytokines in whole blood by physico-chemical induction.

H Meijer1, J Reinecke, C Becker, G Tholen, P Wehling.   

Abstract

OBJECTIVE AND
DESIGN: Cytokines such as interleukin-1 (IL-1) play an important role in degenerative musculo-skeletal diseases, including osteoarthritis, and a multitude of inflammatory disorders. Agents that inhibit the action of such cytokines have a high therapeutic potential in such diseases. Here we describe a new method for enhancing the production of the interleukin-l receptor antagonist (IL-1Ra) and other anti-inflammatory cytokines in whole blood.
MATERIAL AND METHODS: Human venous blood was incubated in the presence of CrSO(4)-treated glass beads. Serum was recovered and the concentrations of IL-1Ra and other relevant cytokines were measured by ELISA.
RESULTS: The interaction of the glass bead surface with cells in whole blood increased production of IL-1Ra and anti-inflammatory cytokines. Removal of the beads and centrifugation generated a serum preparation enriched in anti-inflammatory cytokines. This preparation is of therapeutic value in treating various inflammatory and degenerative disorders.
CONCLUSIONS: The increased de novo production of anti-inflammatory cytokines by a direct physico-chemical induction of whole blood in the Orthokin system is feasible and offers an alternative, novel approach to treating mild to moderate OA and other orthopaedic conditions such as degenerative spine diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14520515     DOI: 10.1007/s00011-003-1197-1

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  42 in total

1.  [Intra-articular therapy with autologous interleukin-1 receptor antagonist in osteoarthritis. Innovation or quackery?].

Authors:  D Stengel; A Ekkernkamp; M Wich
Journal:  Unfallchirurg       Date:  2004-11       Impact factor: 1.000

Review 2.  [Biotechnological therapies for the treatment of back pain: alternatives to corticosteroids].

Authors:  C Moser; H-J Thiel; D Grönemeyer
Journal:  Orthopade       Date:  2013-12       Impact factor: 1.087

Review 3.  Emerging role of extracellular vesicles in inflammatory diseases.

Authors:  Edit I Buzas; Bence György; György Nagy; András Falus; Steffen Gay
Journal:  Nat Rev Rheumatol       Date:  2014-02-18       Impact factor: 20.543

Review 4.  Neuroimmune modulation of pain and regenerative pain medicine.

Authors:  Thomas Buchheit; Yul Huh; William Maixner; Jianguo Cheng; Ru-Rong Ji
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 5.  Cell Therapy-a Basic Science Primer for the Sports Medicine Clinician.

Authors:  Bijan Dehghani; Scott Rodeo
Journal:  Curr Rev Musculoskelet Med       Date:  2019-12

Review 6.  Effectiveness of intra-articular therapies in osteoarthritis: a literature review.

Authors:  Peter Wehling; Christopher Evans; Jana Wehling; William Maixner
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-06-20       Impact factor: 5.346

Review 7.  Neuroinflammation and Central Sensitization in Chronic and Widespread Pain.

Authors:  Ru-Rong Ji; Andrea Nackley; Yul Huh; Niccolò Terrando; William Maixner
Journal:  Anesthesiology       Date:  2018-08       Impact factor: 7.892

Review 8.  Innovative regenerative medicine in the management of knee OA: The role of Autologous Protein Solution.

Authors:  Nicolò Danilo Vitale; Filippo Vandenbulcke; Emanuele Chisari; Francesco Iacono; Laura Lovato; Berardo Di Matteo; Elizaveta Kon
Journal:  J Clin Orthop Trauma       Date:  2018-08-23

9.  Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection.

Authors:  Marijn Rutgers; Daniël B F Saris; Wouter J A Dhert; Laura B Creemers
Journal:  Arthritis Res Ther       Date:  2010-06-10       Impact factor: 5.156

10.  Use of autologous platelet-rich plasma to treat muscle strain injuries.

Authors:  Jason W Hammond; Richard Y Hinton; Leigh Ann Curl; Joaquin M Muriel; Richard M Lovering
Journal:  Am J Sports Med       Date:  2009-03-12       Impact factor: 6.202

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.